Helius Medical Technologies Inc HSDT.OQ HSDT.O is expected to show a fall in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025
The Newtown Pennsylvania-based company is expected to report a 58.8% decrease in revenue to $75 thousand from $182 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Helius Medical Technologies Inc is for a loss of $128.50 per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated August 8 at 13:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)